Novo Holdings Iovance Biotherapeutics, Inc. Transaction History

Novo Holdings

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$6.38 - $18.33 $5.34 Million - $15.3 Million	-836,518 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$20.35 - $26.63 $3.28 Million - $4.3 Million	161,358 Added 23.9%	836,518 $20.6 Million
Q2 2021 Aug 16, 2021	BUY	$16.33 - $33.07 $3.48 Million - $7.06 Million	213,349 Added 46.2%	675,160 $17.6 Million
Q1 2021 May 17, 2021	BUY	$28.67 - $52.59 $2.23 Million - $4.09 Million	77,694 Added 20.23%	461,811 $14.6 Million
Q4 2020 Feb 16, 2021	SELL	$28.04 - $50.26 $23,020 - $41,263	-821 Reduced 0.21%	384,117 $17.8 Million
Q3 2020 Nov 16, 2020	BUY	$27.75 - $36.3 $10.7 Million - $14 Million	384,938 New	384,938 $12.7 Million

313

237M

3.77M

1.7M

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $1.18B
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

Get notified when there are updates to the investment portfolio of Novo Holdings, based on Form 13F filings with the SEC.

Stay updated on Novo Holdings with notifications on news.